Closed System Drug-Transfer Device (CSTD) Market to Reach USD 3.8 Billion by 2034

Pune, India, November 7, 2025 - The Global Closed System Drug-Transfer Device (CSTD) Market is projected to grow from USD 1.9 billion in 2024 to approximately USD 3.8 billion by 2034, registering a CAGR of 7.0% during the forecast period (2025-2034), according to Exactitude Consultancy. The market is being driven by the rise in hazardous drug exposure risks among healthcare professionals, coupled with the growing use of CSTDs in oncology and specialty pharmacy compounding.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49068

Key Takeaways
• Market Size (2024): USD 1.9 Billion
• Forecast (2034): USD 3.8 Billion
• CAGR (2025-2034): 7.0%
• Key Segments: Type, Technology, End User, and Region
• Leading Companies: Becton, Dickinson and Company (BD), ICU Medical Inc., Equashield LLC, Corvida Medical, Baxter International Inc., Yukon Medical, Braun Melsungen AG, and Simplivia Healthcare.

Market Story
Closed System Drug-Transfer Devices (CSTDs) are essential in modern healthcare facilities to prevent occupational exposure to cytotoxic and hazardous drugs during compounding, preparation, and administration. The devices create a sealed, leak-proof system that minimizes drug vapor escape and microbial contamination-crucial for healthcare worker safety and drug sterility.

The market's growth is primarily driven by the increasing incidence of cancer cases worldwide and the expanding use of chemotherapy drugs that require stringent handling safety. The introduction of innovative designs such as needleless connectors, automated compounding systems, and integrated vial adaptors is enhancing efficiency and compliance in hospital pharmacies and oncology units.

Regulatory guidelines by agencies such as the U.S. National Institute for Occupational Safety and Health (NIOSH) and USP (800) standards are compelling hospitals to integrate CSTDs into routine oncology workflows. Furthermore, global healthcare modernization and investment in sterile drug compounding facilities are accelerating device adoption across developed and emerging regions.

Market Segmentation
By Type:
Membrane-to-Membrane Systems, Needleless Systems

By Technology:
Diaphragm-Based, Compartmentalized, Air Filtration, Luer-Lock

By End User:
Hospitals, Oncology Centers, Specialty Pharmacies, Clinics, Research & Academic Institutes

By Region:
North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/49068/closed-system-drug-transfer-device-market

Recent Developments
• BD (Becton, Dickinson and Company) launched TexiumTM CSTD Portfolio integrating seamless connections with automated IV preparation systems.
• ICU Medical Inc. expanded its ChemoLock® CSTD line featuring dual-membrane leak prevention technology.
• Equashield LLC introduced ProGuardTM, a next-generation fully closed CSTD with built-in pressure equalization.
• Simplivia Healthcare partnered with health systems in Europe to implement standardized CSTD training programs.
• Corvida Medical received U.S. FDA clearance for its HaloTM CSTD platform, designed for both hazardous and non-hazardous drugs.

Expert Insight
"CSTDs are redefining safety standards in oncology and pharmacy practice. With stringent regulations and new-generation devices ensuring airtight protection, healthcare institutions are prioritizing worker safety as a non-negotiable standard,"
- Lead Medical Devices Analyst, Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49068

Market Drivers
• Rising Cancer Prevalence: Growing chemotherapy volumes and hazardous drug exposure risk.
• Regulatory Mandates: Enforcement of USP and NIOSH guidelines across hospitals and pharmacies.
• Technological Advancements: Development of leak-proof, needleless, and automated CSTD systems.
• Healthcare Worker Safety Awareness: Global focus on occupational health in oncology and clinical pharmacy.

Forecast & Regional Insights
North America dominates the global CSTD market, accounting for over 45% of total revenue in 2024, supported by advanced oncology infrastructure, strict regulatory standards, and early adoption of automated compounding technologies. Europe follows with growing implementation of CSTD compliance protocols across hospitals. The Asia-Pacific region is projected to register the fastest CAGR of 7.9%, driven by rapid healthcare infrastructure expansion, increasing chemotherapy drug usage, and rising occupational safety awareness in India, China, and Japan.

Conclusion
The closed system drug-transfer device market is poised for robust expansion as healthcare institutions worldwide move toward safer, more efficient drug handling practices. With continuous technological innovation and evolving regulatory mandates, CSTDs are becoming a global benchmark for protecting healthcare workers and ensuring drug purity during compounding and administration.

This report is also available in the following languages : Japanese (クローズドシステム薬剤移送デバイス市場), Korean (폐쇄형 시스템 약물 전달 장치 시장), Chinese (封闭式药物转移装置市场), French (Marché des dispositifs de transfert de médicaments en système clos), German (Markt für geschlossene Arzneimitteltransfergeräte), and Italian (Mercato dei dispositivi di trasferimento dei farmaci a sistema chiuso), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/49068/closed-system-drug-transfer-device-market#request-a-sample

Related Reports
Idiopathic Gastroparesis Drugs Market
https://exactitudeconsultancy.com/reports/75695/idiopathic-gastroparesis-drugs-market

Artificial Intelligence (AI) In Drug Discovery Market
https://exactitudeconsultancy.com/reports/75711/artificial-intelligence-ai-in-drug-discovery-market

Clinical Chemistry Market
https://exactitudeconsultancy.com/reports/75735/clinical-chemistry-market

Protein Microarray Market
https://exactitudeconsultancy.com/reports/75742/protein-microarray-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.